Vanberra Signal

RareCan

Curated by Signal

Online cancer patients database collecting system for clinical trial researchers

Overview

Online cancer patients database collecting system for clinical trial researchers. The company has developed a platform that allows patients to share their medical data and experience with cancer researchers. It enables professionals to access the medical database of patients with consent for drug development and clinical trial studies.

Key facts

Founded
2019

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online platform for matching clients with therapists for mental health support

    Health TechnologyLondon, United Kingdom
  • Provider of app for tracking mental fitness and sleep

    Health TechnologyLondon, United Kingdom
  • Digital therapeutic tool for helathacre providers

    Health TechnologyUnited Kingdom

About RareCan

What does RareCan do?

Online cancer patients database collecting system for clinical trial researchers.

Where is RareCan headquartered?

RareCan is headquartered in Hexham, United Kingdom.

When was RareCan founded?

RareCan was founded in 2019.

Which sector is RareCan in?

RareCan operates in Health Technology.

Who are RareCan's competitors?

Companies similar to RareCan include CuraMind, Kelaa, and UThrive.